PARTNERSHIP OPPORTUNITIES

Stelect is currently accepting expressions of interest for potential partnership and Series A investment opportunities (~ June '20).

 

You'll find some of the must-have information on this page, however, if you would like further in-depth information regarding our Technology and the Innovator's behind it, get in touch with us today.

STELECT TEAM

ELISE SUTHERLAND

Co-founder & CEO

Elise completed a Bachelor of Science in Mechanical Engineering and a Masters of Biomedical Engineering with Business at The University of Melbourne in 2017. Elise has previous work experience working in some small to large corporate businesses in the healthcare sector.  At Stelect, Elise is responsible for the development and execution of the commercialisation strategy along with investment.

  • LinkedIn Social Icon

ANURUPA SHAW

Lead Sensor Design Engineer

Anurupa received her Bachelor of Technology degree in Mechanical Engineering in 2011 from National Institute of Technology, Durgapur, India. She completed her Master in Science degree from Georgia Institute of Technology, USA (France Campus), in 2014, and her PhD at FEMTO-ST, France, in Engineering Sciences and Micro-techniques in 2017. She has a background in acoustics, and has experience in micro and nano fabrication, and transducer design. Her research interests include ultrasonics, acousto-optics, elastic-wave propagation, piezoelectric materials, non- destructive testing and evaluation, characterization of micro-systems and nano-structures, SAW and BAW devices, and printed electronics.

 
 

STELECT ADVISORY BOARD

OUR PARTNERS

K&L Gates is Stelects's IP partner, working on both our IP Strategy and the filing of Stelect's patents.

KLGates.png

DR ANDREW AJANI

Clinical Advisor

Andrew is an experienced Interventional Cardiologist and is the current director of Melbourne Interventional Group. Andrew is active in cardiology education, holding associate Professorships at The University of Melbourne and Monash University. Andrew was the lead clinician in interventional cardiology startup, IntelliMedical Technologies which developed a steerable guide wire. IntelliMedical was acquired by Merit Medical in 2018.

actuator.png

Stelect joined The Actuator in July 2018. The Actuator is Australia's largest MedTech accelerator and provides support around commercialisation, product development and investment.

Stelect was the winner of the The Actuator's 2017 MedTech's Got Talent as the most investable startup of 2018.

artesian.png

Artesian Investment, an Australian Venture Capital Firm, invested in Stelect in August 2018, October 2018 and in May 2019.

Procept is Stelect's product development partner, with a particular focus on sensor R&D.

Procept-Logo-master-small.png

OUR TECHNOLOGY

Stelect's novel medical device is aimed at increasing the accuracy rate in coronary stent selection. The Stelect Tech utilises ultrasound technology in order to assist clinicians with the evaluation of coronary artery blockages.

Learn more about our the Stelect Tech by clicking the button below.

CONTACT US

  • LinkedIn Social Icon
  • Twitter Social Icon

Goods Shed North, 710 Collins St, Docklands, VIC 3008